Committee MemberEmploymentConsultantSpeakers BureauOwnership/Partnership/PrincipalPersonal ResearchInstitutional, Organizational, or Other Financial BenefitExpert Witness
John W. Hirshfeld, Jr. (Chair)Hospital of the University of Pennsylvania Cardiac Catheterization Lab—Professor of MedicineNoneNoneNoneNoneNoneNone
Victor A. Ferrari (Co- Chair)Hospital of the University of Pennsylvania—Professor of Medicine and RadiologyNoneNoneNoneNoneNoneNone
Frank M. BengelMedizinische Hochschule Hannover—Direktor, Klinik Fur Nuklearmedizin
  • GE Healthcare

  • Siemens Medical Solutions

NoneNone
  • Siemens Medical Solutions

NoneNone
Lisa BergersenBoston Children’s Hospital—Associate in Cardiology; Harvard Medical School—Associate Professor of Pediatrics
  • 480 Biomedical Inc

NoneNoneNoneNoneNone
Charles E. ChambersPenn State Milton S. Hershey Medical Center—Professor of Medicine & RadiologyNoneNoneNoneNoneNoneNone
Andrew J. EinsteinColumbia University Medical Center—Associate Professor of Medicine (in Radiology)
  • International Atomic Energy Agency

  • Radiation Effects Research Foundation (Hiroshima, Japan)

  • Spectrum Dynamics

None
  • GE Healthcare

  • Philips Medical Systems

  • Toshiba America Medical Systems

NoneNone
Mark J. EisenbergJewish General Hospital McGill University—Professor of MedicineNoneNoneNoneNoneNoneNone
Mark A. FogelChildren’s Hospital of Philadelphia Division of Cardiology—Associate Professor of Pediatrics, Cardiology & RadiologyNoneNoneNone
  • Edwards Scientific

  • Kerios

None
Thomas C. GerberMayo Clinic, Rochester—Professor of Medicine and RadiologyNoneNoneNoneNoneNoneNone
David E. HainesWillliam Beaumont Hospital—Director, Heart Rhythm CenterNoneNoneNone
  • Boston Scientific

  • Medtronic

NoneNone
Warren K. LaskeyUniversity of New Mexico School of Medicine—Professor of Medicine Chief, Division of CardiologyNoneNoneNoneNoneNoneNone
Marian C. LimacherUniversity of Florida—Professor of Medicine, Division of Cardiovascular MedicineNoneNoneNoneNoneNoneNone
Kenneth J. NicholsNorthwell Health, Division of Nuclear Medicine and Molecular Imaging—Senior Physicist; Hofstra University—Professor of Radiology
  • Syntermed Inc.

NoneNoneNoneNoneNone
Daniel A. PrymaPerelman School of Medicine at the University of Pennsylvania—Associate Professor of Radiology & Radiation Oncology; Chief, Nuclear Medicine & Clinical Molecular ImagingNoneNoneNone
  • Advanced Accelerator Applications

  • Bayer Healthcare Pharmaceuticals

  • Progenics Pharmaceuticals

  • Siemens

NoneNone
Gilbert L. RaffWilliam Beaumont Hospital—Medical Director, Advanced Cardiovascular ImagingNoneNoneNoneNoneNoneNone
Geoffrey D. RubinDuke University Medical Center—Professor of Radiology and Bioengineering
  • Fovia

  • GE Healthcare

None
  • Terarecon

  • HeartFlow

NoneNoneNone
Donnette SmithMended Hearts—Executive Vice PresidentNoneNoneNoneNoneNoneNone
Arthur E. StillmanEmory University Hospital—Professor of Radiology & Imaging Sciences; Professor of MedicineNoneNoneNoneNoneNoneNone
Suma A. ThomasCleveland Clinic Heart and Vascular Institute—Vice-Chairman Strategic OperationsNoneNoneNoneNoneNoneNone
Thomas T. TsaiDenver VA Medical Center; University of Colorado Denver—Director Interventional Cardiology; Assistant Professor; CCOR Group-InvestigatorNoneNoneNoneNoneNoneNone
Louis K. WagnerUniversity of Texas/Houston Medical School Department of Radiology—ProfessorNoneNoneNoneNoneNoneNone
L. Samuel WannUniversity of Wisconsin, Madison and Medical College of Wisconsin, Milwaukee— Clinical Professor of Medicine
  • Astellas Pharmaceutical

  • United Healthcare

NoneNoneNoneNoneNone

This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.

According to the ACC, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.

CCOR = Colorado Cardiovascular Outcomes Research; VA = Veterans Affairs.

  • Significant relationship.

  • No financial benefit.